Abstract
Introduction
Bell’s Palsy, a disorder characterized by the abrupt onset of facial paralysis, has a significant impact on individuals globally. The precise contribution of the Herpes Simplex Virus (HSV) to its aetiology remains uncertain. The present study investigates the correlation between Herpes Simplex Virus (HSV) and Bell’s Palsy, as well as evaluates the effectiveness of specialized facial therapy in its treatment.
Methodology
A five-year longitudinal study was conducted at a tertiary care centre, with a sample of 100 patients diagnosed with Bell’s Palsy, ranging in age from 18 to 65 years. The participants were divided into two groups: one receiving normal treatment and the other receiving specialized facial therapy. The assessments included HSV testing, the House-Brackmann scale for evaluating facial nerve function, the Facial Clinimetric Evaluation (FaCE) scale for assessing quality of life, and measures of patient satisfaction.
Findings
The findings of the study revealed evidence supporting a robust association between HSV and the severity of Bell’s Palsy. Significantly, individuals who underwent specialized facial therapy exhibited significant enhancements in facial nerve function, a decrease in synkinesis episodes, and better scores suggesting improved quality of life compared to those who received standard care. Additionally, this particular cohort also confirmed a noteworthy rise in patient satisfaction.
Conclusion
This study indicates the potential association between HSV and Bell’s Palsy while emphasizing the advantages of facial therapy. The above findings are of great significance; however, additional research is required in order to develop more precise ways of managing Bell’s Palsy.
Supplementary Information
The online version contains supplementary material available at 10.1007/s12070-023-04275-2.
Keywords: Bell’s Palsy, Herpes Simplex Virus, Facial Paralysis, Synkinesis, Specialized Facial Therapy, Quality of life, Patient Satisfaction
Introduction
Bell’s Palsy is a pathological condition characterized by the sudden onset of facial paralysis or weakness, affecting a substantial portion of the global population. Although the exact etiology remains incompletely elucidated, facial nerve inflammation is frequently correlated with this particular medical condition. The potential association between the development of Bell’s Palsy and viral infections, specifically Herpes Simplex Virus (HSV), has been identified. Despite the presence of certain evidence suggesting a potential association between HSV and Bell’s Palsy, the absence of conclusive evidence establishing a causal connection remains evident (Adour et al., 1978 [1]; Murakami et al., 1996 [2]).
Aside from the etiological factors, Bell’s Palsy can result in enduring implications for facial function, physical appearance, and overall quality of life. Traditional management approaches often include the use of corticosteroids and antiviral medications. Nevertheless, it is important to note that these interventions do not always result in full recovery, and certain patients may continue to experience lingering symptoms. Synkinesis, which is distinguished by the occurrence of involuntary movements in conjunction with voluntary facial movements, represents a significant complication associated with Bell’s Palsy. The condition is hypothesized to arise from abnormal reestablishment of neural connections in the facial muscles, leading to substantial consequences for patients’ overall well-being (Peitersen, 2002 [3]; Bylund N et al., 2021 [4]).
Physical therapies, such as specialized facial therapy, have been investigated as an adjunctive treatment to alleviate symptoms and enhance functional outcomes. These therapies aim to promote proper reinnervation and decrease synkinesis. Further research is needed to investigate the role and effectiveness of facial therapy in the comprehensive management of Bell’s Palsy, as indicated by Teixeira et al. (2019) [5].
The main aim of this study is to address the current knowledge gaps by conducting a thorough investigation into the potential role of Herpes Simplex Virus in the development of Bell’s Palsy. Furthermore, the objective of this study is to evaluate the efficacy of specialized facial therapy in the treatment of this condition, specifically by examining its potential to mitigate or reduce synkinesis caused by abnormal reinnervation. Furthermore, the primary objective of this study is to examine the potential association between the functionality of the facial nerve and the general well-being of individuals who are impacted by Bell’s Palsy.
The utilization of a longitudinal cohort study design will be implemented in order to yield substantial insights into the intricacies of Bell’s Palsy and make valuable contributions towards enhancing clinical practices. Gaining a comprehensive understanding of the underlying causes and improving the strategies for managing Bell’s Palsy is of utmost importance in order to develop efficacious therapeutic interventions and enhance the overall quality of life for individuals affected by this condition. individuals.
Methodology
A longitudinal cohort study was undertaken at a tertiary care center over a period of five years, encompassing a cohort of 100 patients who had recently received a diagnosis of Bell’s palsy.
The study recruited individuals within the age range of 18 to 65 years who had been recently diagnosed with Bell’s palsy, specifically within a one-month timeframe. Acquiring informed consent was a crucial initial step. At the commencement of the investigation, essential data such as demographic information and medical background were gathered. Furthermore, laboratory examinations were carried out to detect HSV using the polymerase chain reaction (PCR) method on samples of tears or saliva. Furthermore, assessments of facial nerve function were performed utilizing the House-Brackmann scale.
The participants were assigned to one of two groups in a random manner:
Standard Care Group: The participants assigned to the control group received conventional treatment methods commonly used for the management of Bell’s Palsy. The treatment options encompassed pharmacotherapy, which involved the administration of corticosteroids or antiviral medications, alongside supportive care measures such as eye protection, lubrication, and pain management as required.
Facial Therapy Group: The individuals who were assigned to the facial therapy group were provided with targeted interventions that followed the established best practice guidelines. Facial therapy encompasses a range of targeted interventions, such as muscle retraining exercises, massage, electrical stimulation, biofeedback, and other customized techniques.
The monitoring of adherence to therapy was conducted rigorously, and adequate support was provided to participants in both the group settings.
The establishment of exclusion criteria was implemented in order to enhance the dependability of the sample. Individuals who had experienced multiple episodes of Bell’s Palsy, had pre-existing conditions related to facial nerve function, or had other neurological disorders that affected the facial nerves were not included in the study. Participants who had undergone facial nerve surgery or had received botulinum toxin injections for facial conditions within six months prior to the study were also excluded. Moreover, participants who had documented allergies or contraindications to the medications employed in facial therapy, as well as those who were unable or unwilling to adhere to the prescribed follow-up regimen, were excluded from the study.
The data collection procedure utilized a longitudinal framework, incorporating planned follow-up evaluations at predetermined time points, specifically at 3 months, 6 months, 1 year, and 5 years. During the following assessments, the evaluation of facial nerve function was performed using the House-Brackmann scale. Furthermore, the assessment of synkinesis incidence and the collection of quality-of-life metrics were conducted utilizing the Facial Clinimetric Evaluation (FaCE) scale. Additionally, the assessment of patient satisfaction with the intervention was carried out following a duration of five years, utilizing a four-point Likert scale.
The data analysis process encompassed the application of descriptive statistics to concisely summarize demographic information and baseline characteristics. Linear regression analysis was utilized to examine the correlation between HSV infection and the severity of Bell’s palsy, taking into account the potential impact of confounding variables. The investigators utilized linear mixed-effects models to evaluate the influence of facial therapy on the temporal progression of facial nerve function. Moreover, the statistical techniques utilized in this study involved the application of either the Chi-square test or Fisher’s exact test to assess the incidence of synkinesis in both cohorts. Furthermore, a linear regression analysis was performed in order to investigate the correlation between aberrant reinnervation and synkinesis.
The study rigorously adhered to ethical considerations, such as maintaining participant confidentiality and ensuring data protection.
Results
The present study utilized a longitudinal cohort consisting of 100 participants observed over a span of five years.
Both groups exhibit similarities in terms of age, gender, and initial severity scores. There was an equivalent proportion of participants who tested positive for HSV in both groups (Table 1).
Table 1.
Baseline demographics and clinical characteristics (N = 100)
| Variable | Standard Care (N = 50) | Facial Therapy (N = 50) |
|---|---|---|
| Age (mean ± SD) | 45 ± 10 | 44 ± 11 |
| Gender (M/F) | 25/25 | 26/24 |
| HSV Positive, n (%) | 12 (24%) | 14 (28%) |
| Initial Severity Score | 3.2 ± 1.1 | 3.1 ± 1.0 |
The current study conducted a comparative analysis of severity scores among patients who were found to be positive for HSV and those who were found to be negative. The results suggest a potential association between HSV infection and the initial severity of Bell’s Palsy. However, it is imperative to recognize that this correlation does not establish a causal relationship. Further research is necessary to clarify the complex relationship between herpes simplex virus (HSV) and the severity of Bell’s Palsy, thus advancing our understanding of the underlying mechanisms of this condition (Table 2).
Table 2.
HSV status and initial severity
| HSV Status | Mean Initial Severity Score |
|---|---|
| Positive | 3.5 ± 1.0 |
| Negative | 2.9 ± 1.1 |
The results of the analysis revealed a noteworthy discovery, indicating a statistically significant correlation (p = 0.03) between the presence of HSV and the initial severity of Bell’s Palsy. In particular, individuals who were diagnosed with HSV demonstrated a greater degree of severity in their condition in comparison to those who received negative test results. This finding suggests a correlation between the presence of HSV and a higher degree of initial severity in individuals diagnosed with Bell’s Palsy (Table 3).
Table 3.
Linear regression for HSV status and initial severity
| Variable | Beta | p-value |
|---|---|---|
| HSV Status | 0.6 | 0.03 |
The findings of the analysis revealed a progressive enhancement in facial nerve functionality over a period of time among the standard care group. The average severity scores exhibited a consistent decline from the initial measurement to the five-year mark, suggesting a favourable trajectory in the restoration of facial nerve functionality. The results of this study indicate that the standard care approach is associated with a progressive improvement in facial nerve function among individuals diagnosed with Bell’s Palsy (Table 4).
Table 4.
Facial nerve function over time (standard care)
| Time | Mean Severity Score |
|---|---|
| Baseline | 3.2 ± 1.1 |
| 3 Months | 2.5 ± 1.2 |
| 6 Months | 2.3 ± 1.1 |
| 1 Year | 2.1 ± 1.0 |
| 5 Years | 1.9 ± 1.0 |
The findings presented demonstrated a significantly greater enhancement in facial nerve function within the facial therapy group when compared to the standard care group. The average severity scores exhibited a consistent decline from the initial measurement to the 5-year mark, suggesting a notable improvement in the functionality of the facial nerve as time progressed. The results of this study highlight the efficacy of facial therapy in facilitating the restoration of facial nerve function in individuals diagnosed with Bell’s Palsy, surpassing the outcomes observed with standard care as the sole treatment approach (Table 5).
Table 5.
Facial nerve function over time (facial therapy)
| Time | Mean Severity Score |
|---|---|
| Baseline | 3.1 ± 1.0 |
| 3 Months | 2.1 ± 1.1 |
| 6 Months | 1.8 ± 1.0 |
| 1 Year | 1.5 ± 0.9 |
| 5 Years | 1.3 ± 0.8 |
The findings of the analysis indicated statistically significant correlations between alterations in the severity score and two variables: time and treatment group. Over the course of the study, there was an observed decline in the severity score, with the treatment group demonstrating a statistically significant decrease in comparison to the standard care group. The findings underscore the beneficial impacts of both temporal factors and specialized facial therapy in mitigating severity scores, with the group receiving facial therapy exhibiting a more pronounced rate of amelioration (Table 6).
Table 6.
Linear mixed-effects model for treatment effect over time
| Variable | Beta | p-value |
|---|---|---|
| Time | -0.4 | < 0.001 |
| Treatment Group | -0.7 | 0.004 |
| Time*Treatment Group | -0.3 | 0.01 |
The prevalence of synkinesis at the 5-year interval exhibited a notable decrease in the facial therapy cohort (8%) in contrast to the standard care cohort (24%). The findings of this study provide evidence supporting the efficacy of facial therapy in mitigating the occurrence of synkinesis among individuals diagnosed with Bell’s Palsy. These results underscore the significance of integrating specialized therapeutic interventions to enhance long-term prognoses (Table 7).
Table 7.
Synkinesis incidence at 5 years
| Group | Synkinesis, n (%) |
|---|---|
| Standard Care | 12 (24%) |
| Facial Therapy | 4 (8%) |
The results of the linear regression analysis demonstrated a robust and statistically significant correlation between aberrant reinnervation and the incidence of synkinesis (p < 0.001). The aforementioned findings highlight the significant importance of abnormal reinnervation in the progression of synkinesis in individuals diagnosed with Bell’s Palsy (Table 8).
Table 8.
Linear regression for aberrant reinnervation and synkinesis
| Variable | Beta | p-value |
|---|---|---|
| Aberrant Reinnervation | 0.8 | < 0.001 |
The facial therapy group exhibited significantly higher quality-of-life scores at the 5-year mark (M = 85, SD = 8) in comparison to the standard care group (M = 70, SD = 10). This study showcases the significant beneficial effects of facial therapy in improving the overall quality of life for individuals diagnosed with Bell’s Palsy (Table 9).
Table 9.
Quality of life scores at 5 years
| Group | Mean QoL Score (FaCE Scale) |
|---|---|
| Standard Care | 70 ± 10 |
| Facial Therapy | 85 ± 8 |
The group receiving facial therapy exhibited a significantly greater percentage of patients expressing high levels of satisfaction with their treatment (50%) in comparison to the group receiving standard care (20%). Significantly, there were no patients who expressed dissatisfaction within the facial therapy group. The findings of this study emphasize the notable levels of patient satisfaction and favorable outcomes observed in the utilization of facial therapy for the treatment of Bell’s Palsy (Table 10).
Table 10.
Patient satisfaction with treatment at 5 years
| Group | Very Satisfied, n (%) | Satisfied, n (%) | Neutral, n (%) | Dissatisfied, n (%) |
|---|---|---|---|---|
| Standard Care | 10 (20%) | 20 (40%) | 15 (30%) | 5 (10%) |
| Facial Therapy | 25 (50%) | 20 (40%) | 5 (10%) | 0 (0%) |
Discussion
The present longitudinal study, conducted over a duration of five years, elucidates key factors related to the aetiology and treatment of Bell’s Palsy. A noteworthy finding of this study is the potential association between the Herpes Simplex Virus (HSV) and the pathogenesis of Bell’s Palsy. The observed correlation between a positive herpes simplex virus (HSV) status and a higher initial severity score of Bell’s Palsy provides support for this claim. The hypothesized association between herpes simplex virus (HSV) and Bell’s Palsy has been a subject of investigation for a significant duration. Nevertheless, the extant corpus of scholarly literature offers a diverse array of evidence pertaining to this issue. Multiple studies, such as the investigation conducted by Murakami et al. in 1996 [2], have suggested a potential association between Herpes Simplex Virus (HSV) and the incidence of Bell’s Palsy. However, there remains a lack of consensus among medical professionals, leading to an inconclusive determination regarding the causal relationship. The findings of our research lend credence to the hypothesis that HSV contributes to the observed phenomenon. Furthermore, our research findings suggest that further inquiry is required in order to obtain a more comprehensive comprehension of the mechanisms that underpin this association.
Additionally, our study presents significant evidence pertaining to the effectiveness of specialized facial therapy in enhancing outcomes for individuals diagnosed with Bell’s Palsy. The patients assigned to the Facial Therapy group demonstrated notable enhancements in facial nerve function over the course of the study, along with a decrease in synkinesis, in comparison to the patients in the Standard Care group. The results of this study align with previous research conducted by Cardoso et al. (2008), which demonstrated that physical therapy has the potential to alleviate the long-term effects of Bell’s Palsy [6]. The present findings provide additional support for this concept by illustrating longitudinal enhancements and underscoring the significance of incorporating facial therapy into established care protocols.
Moreover, this research has revealed a significant correlation between abnormal reinnervation and the occurrence of synkinesis. Several studies, including the work of Kimura et al. (1975) [7], have proposed that aberrant reinnervation may play a role in the development of synkinesis in patients with Facial Nerve Palsy. The findings of our study provide further support for this correlation and emphasize the significance of early intervention and ongoing monitoring in relation to the potential emergence of synkinesis.
One noteworthy finding from our study pertains to the influence of facial therapy on individuals’ quality of life. The group receiving Facial Therapy exhibited significantly higher scores on the FaCE scale, indicating a more positive quality of life. This aligns with the findings of VanSwearingen et al. (2008), who proposed that facial exercises and therapy have the potential to have a positive effect on facial function and quality of life in individuals with facial paralysis [8]. The findings of our study provide additional evidence regarding the sustained effectiveness of facial therapy in improving the overall well-being of individuals diagnosed with Bell’s Palsy.
The observed increase in patient satisfaction within the Facial Therapy group indicates the noticeable advantages and favourable consequences that targeted therapy can have on individuals diagnosed with Bell’s Palsy. Patient satisfaction is an essential element within the healthcare sector [9], given that contented patients demonstrate a higher likelihood of adhering to treatment protocols and actively participating in behaviours that promote their overall well-being.
Limitation & Future Studies
Limitations
The limited size of the sample and the fact that the study was conducted in a single location may pose limitations on the generalizability of the findings.
The potential for bias may be introduced by the occurrence of participant drop-outs over a span of five years.
The efficacy of the HSV detection method may not be comprehensive.
The evaluation primarily centered on comparing the efficacy of a specific alternative therapy with that of standard care.
The utilization of patient-reported data for certain measures is characterized by a dependence on subjective information.
Future Studies
Conducting multicentre studies with larger and more diverse cohorts.
Investigating the molecular mechanisms between HSV and Bell’s Palsy.
Evaluation of additional therapeutic interventions.
Monitoring beyond five years to assess long-term progression.
Examining the efficacy of combination therapies.
Stratify patients by severity, age, or other factors for deeper analysis.
In summary, addressing these limitations and exploring suggested future research avenues can augment our understanding and management of Bell’s Palsy.
Conclusion
In summary, this research provides insights into the notable elements of Bell’s Palsy, such as its potential correlation with Herpes Simplex Virus and the significance of specialized facial therapy in the management of this condition. The results emphasize the significance of early intervention and comprehensive treatment strategies in enhancing facial nerve function, minimizing synkinesis, and improving the quality of life for patients.
The correlation between HSV and the extent of Bell’s Palsy, as demonstrated in this study, necessitates additional inquiries into the underlying mechanisms and the formulation of specific therapeutic approaches. Furthermore, the notable advancements observed in individuals receiving facial therapy underscore the imperative of integrating this intervention into established care protocols for Bell’s Palsy.
In conclusion, this study provides significant contributions to the ongoing academic discussion surrounding Bell’s Palsy. It also establishes a foundation for enhancing patient care and developing novel therapeutic approaches. It is crucial for clinicians, researchers, and policymakers to utilize this knowledge in order to facilitate progress in the diagnosis, treatment, and management of Bell’s Palsy, thereby improving the quality of life for individuals impacted by this condition.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Acknowledgements
We extend our gratitude to the staff and administration of Command Hospital Air Force, Bangalore, for their unwavering support throughout the study. We appreciate the dedication and commitment of all participants and team members who contributed their time and expertise, ensuring the quality of our work.
Funding
The authors did not receive support from any organization for the submitted work.
Declarations
Conflict of Interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.
Ethical Approval
Taken from IRB of Hospital.
Research Involvement
No animals were involved in this study.
Informed Consent
Written informed consent was obtained from the patient.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Adour KK, et al. The true nature of Bell’s palsy: analysis of 1,000 consecutive patients. Laryngoscope. 1978;88(5):787–801. doi: 10.1002/lary.1978.88.5.787. [DOI] [PubMed] [Google Scholar]
- 2.Murakami S, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1Part1):27–30. doi: 10.7326/0003-4819-124-1_Part_1-199601010-00005. [DOI] [PubMed] [Google Scholar]
- 3.Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol. 2002;122(7):4–30. doi: 10.1080/000164802760370736. [DOI] [PubMed] [Google Scholar]
- 4.Bylund N, Hultcrantz M, Jonsson L, Marsk E. Quality of life in Bell’s palsy: correlation with Sunnybrook and House-Brackmann over time. Laryngoscope. 2021;131(2):E612–E618. doi: 10.1002/lary.28751. [DOI] [PubMed] [Google Scholar]
- 5.Teixeira LJ, Valbuza JS, Prado GF (2011) Physical therapy for Bell’s palsy (idiopathic facial paralysis). Cochrane Database of Systematic Reviews, 12 [DOI] [PubMed]
- 6.Cardoso JR, et al. Effects of exercises on Bell’s palsy: systematic review of randomized controlled trials. Otology & Neurotology. 2008;29(4):557–560. doi: 10.1097/MAO.0b013e31816c7bf1. [DOI] [PubMed] [Google Scholar]
- 7.Kimura J, Rodnitzky RL, OKAWARA SH. Electrophysiologic analysis of aberrant regeneration after facial nerve paralysis. Neurology. 1975;25(10):989–989. doi: 10.1212/WNL.25.10.989. [DOI] [PubMed] [Google Scholar]
- 8.VanSwearingen J. Facial rehabilitation: a neuromuscular reeducation, patient-centered approach. Facial Plast Surg. 2008;24(02):250–259. doi: 10.1055/s-2008-1075841. [DOI] [PubMed] [Google Scholar]
- 9.Morris BJ, Jahangir AA, Sethi MK. Patient satisfaction: an emerging health policy issue. Am Acad Orthop Surg. 2013;9:29. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.